Introduction. Staphylococcal infections--whatever next?
Bouza
E
E
Servicio de Microbiología Clínica y E. Infecciosas, Hospital Gregorio Marañón, University of Madrid, Madrid, Spain. ebouza@microb.net
D000900:Anti-Bacterial Agents / Q000592:standards; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology / Q000635:transmission; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology / Q000635:transmission; D017576:Daptomycin / Q000592:standards; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology / Q000635:transmission; D013211:Staphylococcus aureus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D017576:Daptomycin